Astra Zeneca CEO to Leave Following Weak Results - Presented by: The Aol. On Network

AstraZeneca PLC said Chief Executive David Brennan is leaving after the troubled drug maker missed its first-quarter earnings and sales forecasts and cut its full-year profit targets yet again. Dow Jones's Sten Stovall reports. Photo: Getty Images



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
FCX $ 10.50 0.31 ▲ 3.04%
ATVI $ 29.22 1.29 ▲ 4.62%
BAC $ 16.36 0.08 ▼ 0.49%
AAPL $ 113.29 0.37 ▲ 0.33%
BTU $ 2.39 0.11 ▲ 4.82%
PBR $ 5.78 0.05 ▲ 0.87%
QQQ $ 105.62 0.02 ▼ 0.02%
INTC $ 28.42 0.70 ▲ 2.53%

As of 8/28/2015, 04:15 PM